| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |